BioAxone BioSciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.bioaxonebio.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Cethrin in Acute Cervical Spinal Cord Injury
Phase 2
Withdrawn
- Conditions
- Spinal Cord Injury
- Interventions
- Drug: Cethrin (BA-210)Drug: Placebo
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2014-11-26
- Lead Sponsor
- BioAxone BioSciences, Inc.
- Registration Number
- NCT02053883
Safety and Efficacy of Cethrin® in Adult Subjects With Acute Cervical Spinal Cord Injury
Phase 2
Withdrawn
- Conditions
- Acute Cervical Spinal Cord Injury
- Interventions
- Drug: Cethrin® (BA-210)Procedure: placebo
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- BioAxone BioSciences, Inc.
- Registration Number
- NCT00610337
News
No news found